You're correct in noting that an Impact Factor (IF) of 10 is significant in oncology and hematology, but whether it places a journal in the top 5% depends on the specific field and the total number of journals within that category.
Top Oncology Journals by Impact Factor (2023)
According to the Journal Citation Reports (JCR) and other sources:
-
CA: A Cancer Journal for Clinicians – IF ~503.1
-
Nature Reviews Clinical Oncology – IF ~81.1
-
Annals of Oncology – IF ~56.7
-
Cancer Cell – IF ~48.8
-
Journal of Clinical Oncology – IF ~42.1
-
Lancet Oncology – IF ~41.6
-
Cancer Discovery – IF ~29.7
-
Journal of Hematology & Oncology – IF ~29.5
-
Molecular Cancer – IF ~27.7
-
Nature Cancer – IF ~23.5
-
JAMA Oncology – IF ~22.5
-
Journal of Thoracic Oncology – IF ~21.0
-
Cancer Communications – IF ~20.1
-
Neuro-Oncology – IF ~16.4
-
Journal of the National Comprehensive Cancer Network – IF ~14.8
-
Blood Cancer Journal – IF ~12.9
-
Leukemia – IF ~12.8
-
Cancer Research – IF ~12.5
-
Seminars in Cancer Biology – IF ~12.1
-
JACC: CardioOncology – IF ~12.0 OOIR+2Oncodaily+2OOIR+2BioMed Central+5Scimago+5OOIR+5Wikipedia+3OOIR+3Mike M. Dahl+3
With over 300 oncology journals indexed, an IF of 10 would place a journal within the top 20–25, corresponding to approximately the top 7–8%.
???? Top Hematology Journals by Impact Factor (2023)
Based on available data:
-
Journal of Hematology & Oncology – IF ~29.5
-
Blood – IF ~21.0
-
Circulation Research – IF ~16.5
-
Lancet Haematology – IF ~15.4
-
Blood Cancer Journal – IF ~12.9
-
Leukemia – IF ~12.8
-
American Journal of Hematology – IF ~10.1
-
Experimental Hematology & Oncology – IF ~9.4
-
Haematologica – IF ~8.2
-
HemaSphere – IF ~7.6 Wikipedia+5OOIR+5Impact Factor for Journal+5
In hematology, with fewer journals compared to oncology, an IF of 10 would place a journal within the top 5–7, corresponding to approximately the top 5–7%.
Summary
-
Impact Factor (IF) of 10 is a strong indicator of a journal's influence in both oncology and hematology.
-
In oncology, it places a journal within the top 7–8%.
-
In hematology, it places a journal within the top 5–7%.
Therefore, while an IF of 10 is highly respectable, it may not always correspond exactly to the top 5%, especially in fields with a large number of journals like oncology.
If you're considering submitting your work, targeting journals with an IF around 10 is a strategic choice for high visibility and impact in these fields.